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pithelial protein lost in neoplasm (EPLIN) is a cytoskele-
ton-associated protein encoded by a gene that is
down-regulated in transformed cells. EPLIN increases the
number and size of actin stress ﬁbers and inhibits membrane
rufﬂing induced by Rac. EPLIN has at least two actin binding
sites. Puriﬁed recombinant EPLIN inhibits actin ﬁlament
depolymerization and cross-links ﬁlaments in bundles. EPLIN
does not affect the kinetics of spontaneous actin polymer-
ization or elongation at the barbed end, but inhibits
E
 
branching nucleation of actin ﬁlaments by Arp2/3 complex.
Side binding activity may stabilize ﬁlaments and account
for the inhibition of nucleation mediated by Arp2/3 complex.
We propose that EPLIN promotes the formation of stable
actin ﬁlament structures such as stress ﬁbers at the expense
of more dynamic actin ﬁlament structures such as membrane
rufﬂes. Reduced expression of EPLIN may contribute to the
motility of invasive tumor cells.
 
Introduction
 
Motile cancer cells depend on assembly and disassembly of
actin filaments to extend their leading edges as they move,
so alterations in the expression or properties of actin bind-
ing proteins may influence their invasiveness (Ben-Ze’ev,
1997; Pawlak and Helfman, 2001). Tumor cell move-
ments might be enhanced by overexpression or activating
mutations of proteins that stimulate the actin system or
lower expression or inactivation of proteins that act as negative
regulators of the actin system. Some transformed cells express
reduced levels of tropomyosin or 
 
 
 
-actinin, proteins that
stabilize actin filaments and actin filament bundles, and
restoring their expression can reverse some transformed
phenotypes (Gluck et al., 1993; Braverman et al., 1996).
On the other hand, the increased expression of thymosin
 
 
 
15 and gelsolin, proteins implicated in the disassembly of
the actin filaments, correlates with poor clinical outcome
of cancer patients (Bao et al., 1996; Chakravatri et al.,
2000; Thor et al., 2001).
The assembly of cellular actin filaments requires the creation
of new barbed ends, either de novo or by removing the
capping proteins or severing existing filaments (Pollard et
al., 2000). Activation of Arp2/3 complex is one mechanism
to create new barbed ends de novo. Arp2/3 complex has
little actin nucleation activity (Welch et al., 1997; Mullins et
al., 1998) unless activated by bacterial proteins (Welch et al.,
1997) or WASp family proteins (Machesky et al., 1999;
Rohatgi et al., 1999). Activated Arp2/3 complex forms new
filaments on the side of preexisting filaments, which then
elongate at their free barbed ends. WASp family proteins
are key downstream targets for Rho family GTPases (Higgs
and Pollard, 2000; Rohatgi et al., 2000) that link signals
from chemotaxis or cell adhesion receptors to activation of
Arp2/3 complex.
Epithelial protein lost in neoplasm (EPLIN)* was originally
identified as the product of a gene that is down-regulated
in prostate and breast cancer cell lines (Chang et al., 1998;
Maul and Chang, 1999). In oral keratinocytes and mammary
epithelial cells, it distributes to the cortical cytoskeleton,
whereas in Saos-2 cells, it localizes to actin stress fibers and
focal adhesions (Maul and Chang, 1999; Song et al., 2002;
unpublished data). Two EPLIN isoforms (
 
 
 
 and 
 
 
 
) are
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generated by alternative promoter usage from a single gene
on chromosome 12. EPLIN-
 
 
 
 (85 kD) has an additional
160 residues at its NH
 
2
 
 terminus, but is otherwise identical
to EPLIN-
 
 
 
 (67 kD), the isoform down-regulated in trans-
formed cells. The only domain recognizable in the amino
acid sequence is a centrally located, 54-residue LIM domain,
a putative protein–protein interaction module (Schmeichel
and Beckerle, 1997) that may allow EPLIN to dimerize with
itself or associate with other proteins.
We investigated the possibility that EPLIN might control
cellular actin dynamics. Expression of EPLIN increases the
number and size of cellular stress fibers and inhibits mem-
brane ruffling induced by active Rac1. EPLIN has at least
two actin binding domains. EPLIN stabilizes preformed fila-
ments, a property attributed to its ability to cross-link and
bundle actin filaments. Furthermore, EPLIN inhibits nucle-
ation by Arp2/3 complex. These properties suggest that loss
of EPLIN may contribute to transformation owing to a loss
of stability of mature actin filament structures and more
rapid turnover of filaments associated with motility.
 
Results
 
EPLIN expression increases stress fibers
 
To test if EPLIN modifies actin organization in the cell, we
expressed EPLIN in MCF-7 breast carcinoma cells using a
tetracycline-regulated system. MCF-7 cells do not express
EPLIN-
 
 
 
, but express EPLIN-
 
 
 
 at a low level (Fig. 1 C,
lane 9). Induction of EPLIN expression increased the
number of actin stress fibers and the intensity with which
they stained with rhodamine-phalloidin (Fig. 1 A, B, D,
and E). Expression of EPLIN-
 
 
 
 in MCF-7 cells increased
the fluorescence intensity of rhodamine-phalloidin staining
2.1-fold, whereas expression of EPLIN-
 
 
 
 increased actin
staining 3.7-fold (see Materials and methods). The levels of
EPLIN-
 
 
 
 and -
 
 
 
 overexpression in MCF-7 cells were
equivalent to the levels of endogenous protein in HMEC
and BeWo choriocarcinoma cells, respectively (Fig. 1, C
and F). Staining for the induced EPLIN using anti-Flag
antibodies revealed a positive correlation between the levels
of EPLIN expression and the amount of stress fibers (Fig.
1, G and H).
Figure 1. Expression of EPLIN increases actin filaments in MCF-7 cells. (A, B, D, and E) Expression of Flag-EPLIN-  or -  was induced by 
removing doxycycline from culture media. 72 h after protein induction, cells were fixed and stained with rhodamine-phalloidin to visualize 
actin filaments. A and D,   induction; B and E,   induction. Digital images were captured at the same exposure time (248 ms for A and B; 
308 ms for D and E). (C and F) The levels of EPLIN overexpression in MCF-7 cells were estimated. Varying amounts (2.5–12.5  g) of 
protein lysates from MCF-7 cells before and after protein induction, human mammary epithelial cells (HMEC; EPLIN-  positive), and BeWo 
choriocarcinoma cells (EPLIN-  positive) were fractionated by SDS-PAGE and then immunoblotted with anti-EPLIN antisera. To estimate the 
absolute level of expression, known amounts (0.5–10 ng) of purified his-EPLIN-  protein were also included in the immunoblot. (G and H) 
Flag-EPLIN-  or -  expressing MCF-7 cells were stained with rhodamine-phalloidin and the M2 anti-Flag mAb to stain the induced proteins. 
The increase in actin filaments correlated with the amount of EPLIN expressed in these cells.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
EPLIN stabilizes actin filaments |
 
 Maul et al. 401
 
EPLIN inhibits membrane ruffling
 
Activated Rac1 recruits WAVE/Scar (a member of WASp
family of proteins) from the cytoplasm to the plasma
membrane to induce actin filament assembly (Miki et al.,
1998). To test if EPLIN influences the formation of actin
filaments in vivo, we examined the effect of EPLIN expres-
sion on Rac1-induced membrane ruffling. Expression of
constitutively active Rac1 (HA-tagged Rac1G12V) in HeLa
cells produced extensive membrane ruffles containing
Rac1G12V, actin filaments, and endogenous EPLIN (Fig.
2, A–D). Co-transfection of either EPLIN-
 
 
 
 or EPLIN-
 
 
 
with Rac1G12V strongly inhibited membrane ruffling, pro-
ducing thick actin stress fibers instead (Fig. 2, E–H). When
EPLIN was coexpressed, transfected Rac1G12V was dif-
fusely distributed in the cells, rather than localizing to mem-
brane ruffles.
 
EPLIN binds to actin
 
A recombinant full-length EPLIN-
 
 
 
 GST-fusion protein
purified from bacteria bound actin monomers in a pull-
down assay (Fig. 3 A). Actin monomer binding was efficient
and comparable to the control GST-VCA protein, pelleting
 
 
 
10% of the actin monomers. Truncated EPLIN contain-
ing either the NH
 
2
 
- or COOH-terminal region (GST-
 
  
 
C
and GST-
 
 
 
N) also bound monomeric actin, but less effi-
ciently than the full-length EPLIN-
 
 
 
 (Fig. 3 B). GST-
 
  
 
C/
LIM, lacking the central LIM domain, also bound to mono-
meric actin, but the LIM domain (GST-LIM) failed to bind
monomeric actin. These findings indicate that EPLIN-
 
 
 
contains at least two actin-binding sites, one on each side of
the centrally located LIM domain. Equivalent loading for
the GST-fusion proteins in these experiments was con-
firmed by Coomassie staining.
EPLIN-
 
 
 
 also pelleted with purified actin filaments (Fig.
3 D, lanes 3 and 4). EPLIN-
 
 
 
 alone did not pellet (Fig. 3
D, lanes 1 and 2), indicating that the pelleting is due to
binding to F-actin. Two nonoverlapping truncations of
EPLIN, 
 
 
 
N/LIM (Fig. 3 D, lanes 5–7) and 
 
  
 
C (Fig. 3
D, lanes 8–10), both pelleted with F-actin, indicating the
presence of two independent F-actin binding sites on EP-
LIN-
 
 
 
. BSA, used as negative controls, remained in the su-
pernatant, whereas 
 
 
 
-actinin pelleted with F-actin (Fig. 3
D, lanes 11–14). The stoichiometry of binding was calcu-
lated to be two actin molecules per one his-EPLIN-
 
 
 
 (Fig.
3 E), consistent with the presence of at least two actin-
binding sites per EPLIN-
 
 
 
 polypeptide. Quantitation of
free and pelleted his-EPLIN-
 
 
 
 as a function of actin fila-
ment concentration gave a dissociation equilibrium con-
stant of 
 
 
 
0.1 
 
 
 
M.
 
EPLIN cross-links and/or bundles F-actin
 
The increase in actin stress fibers observed in EPLIN-overex-
pressing cells, together with its localization to the actin cy-
toskeleton, raised the possibility that it may bundle actin fil-
aments. Bundled or cross-linked actin filaments can be
detected by sedimentation at low speed where free actin fila-
ments remain in the supernatant. Because GST can form a
homodimer (Ji et al., 1992), bundling assays were performed
with his-EPLIN-
 
 
 
. His-EPLIN-
 
 
 
 caused the majority of ac-
tin filaments to pellet during low speed centrifugation (Fig.
4 A). At the same molar concentration, EPLIN-
 
 
 
 pelleted
actin filaments more efficiently than 
 
 
 
-actinin, a dimeric
cross-linking protein with two actin-binding sites. A control
protein, BSA, remained in the supernatant with the actin fil-
aments. We used electron microscopy of negatively stained
specimens to confirm that bundling was responsible for ac-
Figure 2. EPLIN inhibits membrane ruffling induced by Rac1. Transfected HeLa cells were stained with anti-HA (A, C, E, and G), rhodamine-
phalloidin (B, F, and H), or anti-EPLIN (D) to visualize the transfected HA-tagged Rac1G12V, actin filaments, or endogenous EPLIN, respectively. 
In A–D, HeLa cells were transfected with HA-tagged Rac1G12V alone. In E–H, HeLa cells were co-transfected with HA-tagged Rac1G12V 
and EPLIN-  (E and F) or EPLIN-  (G and H).T
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tin filaments pelleting with EPLIN during low speed centrif-
ugation. Actin filaments formed thick, tightly packed bun-
dles in the presence of EPLIN-
 
 
 
 (Fig. 4 B). In the presence
of BSA (used as a negative control), the F-actin remained as
thin wavy filaments (Fig. 4 C).
 
EPLIN inhibits actin depolymerization in vitro
 
We used the fluorescence of pyrene-labeled actin to monitor
polymerization and to test if EPLIN affects actin assembly
or disassembly. The time course of spontaneous polymeriza-
tion was the same in the presence or absence of EPLIN-
 
 
 
(see Fig. 6). On the other hand, EPLIN significantly delayed
actin filament depolymerization (Fig. 5 A). When diluted
below the critical concentration, actin filaments depolymer-
ized with a half-time of 7 min. EPLIN-
 
 
 
 slowed depolymer-
ization in a concentration-dependent fashion. Addition and
loss of actin monomers occurs exclusively at the filament
ends, with the barbed ends displaying higher rates of turn-
over (Pollard et al., 2000). We tested the possibility that EP-
LIN-
 
 
 
 stabilizes filaments by capping barbed ends (Fig. 5
B). The rate of barbed end elongation from spectrin-actin
seeds was not affected by EPLIN-
 
 
 
, indicating that the EP-
LIN-
 
 
 
 does not cap barbed ends.
 
EPLIN inhibits nucleation of actin polymerization 
by Arp2/3 complex
 
The ability of EPLIN-
 
 
 
 to bind the sides of actin filaments
and bundle them suggested that EPLIN might influence the
ability of filaments to serve as secondary activators of actin
filament nucleation by Arp2/3 complex. Arp2/3 complex ac-
tivated by Scar-WA stimulates actin assembly after a short
lag time (Fig. 6 A). This lag is attributed to the time re-
quired to form enough actin filaments to serve as secondary
activators of branching nucleation (Higgs et al., 1999; Ma-
chesky et al., 1999; Pantaloni et al., 2000).
EPLIN-
 
 
 
 had no effect on the time course of spontaneous
polymerization of actin alone or with Scar-WA. However, it
increased the initial lag when actin was polymerized with
Arp2/3 complex and Scar-WA (Fig. 6 A). The lag depended
on the concentration of EPLIN-
 
 
 
. A concentration of 35
Figure 3. EPLIN binds directly to both G- and F-actin. (A) Actin monomer pull-down assay with GST-EPLIN. Glutathione-Sepharose beads 
carrying 2  g of GST-EPLIN-  (lane 1), GST-VCA (lane 2), and GST (lane 3) were incubated with 50 nM G-actin in 0.5 ml. G-actin bound to 
the beads was assayed by immunoblotting with anti-actin antibodies (top). In lanes 4–6, varying amounts of G-actin (2.5–7.5% of the input) 
were included to estimate the amount of bound G-actin. A duplicate gel was stained with Coomassie blue to estimate the amounts of GST 
proteins present in each lane (bottom). GST-VCA contains a G-actin–binding verprolin (V) homology domain, a cofilin (C) homology domain, 
and an acidic segment (A) of bovine N-WASp. (B) Actin monomer pull-down assays were performed with GST-EPLIN-  (lane 1), GST- N 
(lane 2), GST-  C (lane 3), GST-  C/LIM (lane 4), and GST-LIM (lane 5). (C) Schematic diagrams of EPLIN truncations used in the actin 
monomer pull-down assay are shown. (D) Actin filament pelleting assay. Samples containing 16  M polymerized actin and 2  M EPLIN-  
were centrifuged at high speed. Control proteins (BSA, negative controls;  -actinin, positive control) were also used at 2  M. The presence 
( ) or absence ( ) of actin in the pelleting assay is denoted. The supernatant (S) and pellet (P) were analyzed by SDS-PAGE and stained with 
Coomassie blue. Positions of control proteins and EPLIN- , or its truncated derivatives, his-EPLIN N/LIM and his-EPLIN  C, are indicated 
by filled circles. (E) Binding of his-EPLIN-  to actin filament. His-EPLIN-  (0–8  M) was mixed with 10  M polymerized actin, followed by 
ultracentrifugation. Amounts of the free and bound his-EPLIN-  in the supernatant and pellet fractions were determined from a digitized 
Coomassie-stained gel.T
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nM GST-EPLIN-
 
 
 
 nearly doubled the lag time (Fig. 6 B,
filled square). The concentration of barbed ends created by
Arp2/3 complex remained unaffected at up to 105 nM
GST-EPLIN-
 
 
 
 (Fig. 6 B, filled triangle). His-EPLIN-
 
 
 
 fu-
sion protein similarly increased the lag period in a con-
centration-dependent manner at nanomolar concentrations
(unpublished data).
These observations suggest that binding of EPLIN-
 
 
 
 to
the sides of actin filaments might prevent secondary activa-
tion of nucleation, such that nucleation mediated by Arp2/3
complex is delayed until polymerization saturates the fila-
ment-binding capacity of EPLIN. Consistent with this in-
terpretation, addition of preformed actin filaments de-
creased the lag time, and this effect was partially inhibited
by EPLIN-
 
 
 
 in a concentration-dependent manner (Fig. 6
C). In this set of experiments, profilin was included to sup-
press spontaneous nucleation (Machesky et al., 1999; Ro-
hatgi et al., 1999), thereby increasing the lag time to ac-
centuate the effect of added filaments. Together, these
experiments suggest that actin filaments bound by EPLIN-
 
 
 
are poor secondary activators of nucleation mediated by
Arp2/3 complex.
 
EPLIN reduces the formation of branched actin filaments
 
If EPLIN delays actin filament nucleation mediated by
Arp2/3 complex by binding and sequestering actin fila-
Figure 4. EPLIN cross-links and bundles F-actin. (A) Low speed pelleting assay. Samples containing 10  M F-actin and 0.4–2.5  M 
his-EPLIN-  or 0.4– 2.5  M  -actinin were centrifuged at 8,000 g for 20 min. The negative control, BSA, was used at 2.5  M. The supernatant 
(S) and pellet (P) were analyzed by SDS-PAGE and stained with Coomassie blue. Positions of his-EPLIN- ,  -actinin, and BSA are indicated 
by filled circles. (B and C) Electron microscopy. 2  M actin was polymerized with 1  M his-EPLIN-  (B) or 1  M BSA (C), negatively stained 
with uranyl acetate and visualized by electron microscopy. The boxed areas were enlarged (insets) to better illustrate actin filaments.
polymerization buffer contained 2  M actin (5% pyrene labeled), 
9 nM spectrin-actin seeds, and   100 nM EPLIN- . In the pres-
ence of capping protein, actin polymerization was inhibited by 
 90% (not depicted).
Figure 5. Effect of EPLIN on actin filament depolymerization 
and barbed-end elongation. (A) Time course of the depolymerization 
of actin filaments in the presence of EPLIN, capping protein, 
and  -actinin. Actin was polymerized with capping protein, EPLIN, 
or  -actinin, and was then diluted 20-fold into polymerization 
buffer to initiate depolymerization. The final protein concentration 
in the samples were 0.1  M actin,   0.15  M capping protein, 
  10 or 100 nM GST-EPLIN- , and   0.25  M  -actinin. The 
actin polymer concentration was monitored over time using 
pyrene fluorescence. (B) Time course of actin filament elongation 
from barbed ends provided by spectrin-actin seeds. Samples in T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
404 The Journal of Cell Biology | Volume 160, Number 3, 2003
ments, the formation of branched filaments should be inhib-
ited. By fluorescence microscopy, we measured branching of
the products produced by Arp2/3 complex. After 2 min of
polymerization in the presence of activated Arp2/3 complex,
most (88%) of the products were short, branched filaments
(Fig. 7). EPLIN-  reduced the fraction of branched fila-
ments in a concentration-dependent fashion. Similar to the
pyrene fluorescence assay, the inhibition occurred at nano-
Figure 6. EPLIN inhibits actin nucleation by Arp2/3 complex. (A) The time course of actin polymerization was monitored by pyrene 
fluorescence. Samples contained 4  M G-actin (5% pyrene labeled),   15 nM Arp2/3 complex, or   300 nM Scar-WA domain,   varying 
concentrations of GST-EPLIN-  in polymerization buffer. (B) Dependence of the lag time and concentration of ends produced by Arp2/3 
complex on the concentration of EPLIN- . The polymerization lag time was defined as the time required to achieve 10% of the maximum 
fluorescence. The concentration of barbed ends was calculated from elongation rate (measured by the rate of polymerization where 80% of 
monomers were polymerized) using the equation: [barbed ends]   elongation rate/(k  [actin monomer]), where k    10  M
 1 s
 1. At GST-
EPLIN-  concentrations  105 nM, polymerization was incomplete in the time course of the experiment, disallowing determination of the lag time 
or the concentration of barbed ends. (C) The effect of EPLIN on the ability of preformed actin filaments to stimulate nucleation by Arp2/3 complex. 
Samples in polymerization buffer contained 2  M G-actin (5% pyrene labeled), 15 nM Arp2/3 complex, 300 nM Scar-WA domain, and 8  M 
profilin-I,   100 nM actin filament,   10 or 50 nM GST-EPLIN- . Profilin-I was added to accentuate the polymerization lag time.
Figure 7. Effect of EPLIN on the 
morphology of filaments formed by 
Arp2/3 complex. (A and B) Fluorescence 
micrographs of actin filaments nucleated 
by Arp2/3 complex in the absence (A) or 
presence (B) of EPLIN. Samples contained 
4  M G-actin (5% pyrene labeled), 30 nM 
Arp2/3 complex, 100 nM Scar-WA 
domain, and varying concentrations 
of GST-EPLIN-  (0–900 nM) in 
polymerization buffer. Polymerization was 
performed in 4  M rhodamine-phalloidin, 
which stabilizes branched structure by 
inhibiting phosphate release from ADP-Pi-
actin filaments and allows visualization of 
filaments by fluorescence microscopy. 
Polymerization was allowed to proceed 
for 2 min before being quenched by 
dilution. (C) Quantitation of branched and 
unbranched filaments. The chi-squared 
test was used to calculate the p-values.T
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molar concentrations of EPLIN- , reducing the fraction of
branched filaments to 62% at 9 nM, 55% at 90 nM, and
17% at 900 nM. As seen in the kinetic studies, the inhibi-
tion of branch formation was transient; even with 900 nM
EPLIN- , the frequency of branches increased to 42% after
15 min of polymerization.
Discussion
Our work provides evidence that EPLIN regulates actin-
based structures in cells. Expression of EPLIN in MCF-7
cells increased the number and size of stress fibers. In addi-
tion, expression of EPLIN inhibited Rac1-induced mem-
brane ruffling in HeLa cells. Biochemical studies revealed
three important properties of EPLIN that provide clues
about its functions. First, EPLIN-  contains more than
one actin binding site and is capable of cross-linking and
bundling actin filaments. Second, EPLIN-  stabilizes actin
filaments in vitro. Third, EPLIN-  inhibits actin nucle-
ation by Arp2/3 complex. These properties may favor bun-
dles of actin filaments in cells relative to protrusion of the
leading edge.
Both GST-pull-down and F-actin cosedimentation assays
indicate that the NH2-terminal half and COOH-terminal
half of EPLIN-  bind independently to actin monomers.
The two halves share no recognizable repeats in the primary
sequence, indicating that the two actin-binding domains are
unrelated. Both actin-binding domains are also capable of
binding filaments, although the filament binding is more ef-
ficient for the COOH-terminal half of EPLIN-  (unpub-
lished data). Therefore, the two actin-binding domains of
EPLIN-  may have different roles in the cell.
Low speed pelleting and electron microscopy showed that
EPLIN-  bundles actin filaments. Cross-linking and bun-
dling require a minimum of two actin-binding sites per
cross-linking unit. His-EPLIN-  elutes in size-exclusion
chromatography with Stokes radius of  61 Å (unpublished
data). This unusually high Stokes radius corresponds to a
globular particle with a maximum molecular mass of 781
kD; an asymmetric particle would have a lower molecular
mass. Sedimentation equilibrium analytical ultracentrifuga-
tion of three concentrations of his-EPLIN-  gave an average
molecular mass of 621 kD. This initial characterization indi-
cates that his-EPLIN-  is a slightly asymmetric oligomer of
 8 polypeptides. Additional work is required to determine
how much of this aggregation is attributable to self-associa-
tion of LIM domains or if the his-tag contributes. The pres-
ence of two independent F-actin binding sites per EPLIN
molecule and the tendency of naive EPLIN to form an oli-
gomer in solution could explain the observed cross-linking.
EPLIN-  also stabilizes actin filaments from depolymer-
ization. We ruled out capping of barbed ends, because EP-
LIN-  does not affect the barbed end elongation or sponta-
neous polymerization. Filament-side binding proteins may
stabilize filaments by altering their structure (Stokes and
DeRosier, 1987) or inhibiting phosphate release from ADP-
actin (Korn et al., 1987), or more speculatively, by forming
bundles. We cannot rule out any of these possibilities, but
favor the idea that EPLIN-  stabilizes filaments by binding
to more than one actin subunit, similar to tropomyosin,
which lowers the monomer dissociation rate constant at the
pointed end (Broschat et al., 1989).
Also similar to tropomyosin (Blanchoin et al., 2001), EP-
LIN inhibits secondary activation of branching nucleation
by Arp2/3 complex. This is revealed by the ability of EP-
LIN-  to increase the lag at the outset of polymerization in
the presence of Arp2/3 complex and Scar-WA, without sig-
nificantly affecting the rate of spontaneous polymerization
or the number of barbed ends created by Arp2/3 complex.
This inhibition occurs early in the reaction when the actin
polymer concentration is below 200 nM and is evident at
nanomolar concentrations of EPLIN. Under these condi-
tions, EPLIN could inhibit secondary activation of Arp2/3
complex either by blocking binding sites on the sides of the
initially formed filaments or by aggregating these filaments.
At these early time points, EPLIN-  reduced the frequency
of branches, but our fluorescence microscopy assay did not
reveal large bundles. High concentrations of EPLIN-  also
reduce the number of barbed ends, an indication that fewer
Arp2/3 complexes have initiated polymerization.
In cells, branching nucleation is tightly regulated spatially,
occurring primarily in the forefront of lamellipodia (Svitkina
et al., 1997; Svitkina and Borisy, 1999). Rac regulates the for-
mation of lamellipodia in mammalian cells by activating
WAVE/Scar (Miki et al., 1998, 2000), presumably by dis-
placing a complex of inhibitory proteins from WAVE/Scar
(Eden et al., 2002). Localization of EPLIN to the membrane
ruffles places it at the site of active remodeling of actin fila-
ments. Furthermore, the finding that EPLIN can inhibit
membrane ruffling induced by Rac1G12V directly supports
our hypothesis that EPLIN inhibits remodeling of the actin
cytoskeleton. The mechanism for this inhibition may rest on
the inhibition of branching nucleation by Arp2/3, as shown
by our biochemical analysis. Alternatively, EPLIN might se-
quester Rac1 or dissociate Rac1 from the plasma membrane,
but EPLIN is not known to interact with Rac1.
The net effect of EPLIN on actin filaments, based on its
known properties, is to inhibit actin turnover. Although any
process that affects either actin assembly or actin disassembly
alters filament turnover, EPLIN is capable of influencing
both assembly (actin nucleation) and disassembly (filament
stability). The mechanism of EPLIN appears to be surpris-
ingly simple, and centers on the presence of two (perhaps
more) actin-binding domains, which allows EPLIN to bind
more than one subunit along the side of an actin filament.
This provides the basis for stabilizing filaments and interfer-
ing with branching by Arp2/3 complex, similar to tropomyo-
sin (Broschat et al., 1989; Blanchoin et al., 2001). Other mul-
tivalent actin-binding proteins, such as dystrophin (Rybakova
et al., 1996), may influence actin dynamics in a similar way.
Cellular events leading to the loss of cytoarchitecture and
enhanced motility in malignant cells have not been fully elu-
cidated. Although these events are frequently attributed to
aberrant activation of receptor tyrosine kinases or Rho
GTPases, our study raises the possibility that actin filament–
binding proteins may function to limit dynamic remodeling
of actin filaments to regulate cell motility. The loss of ex-
pression or function of EPLIN in cancer cells would then re-
move this regulatory mechanism to enhance cell motility
and/or invasion.T
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Materials and methods
EPLIN expression in cells
The coding region of EPLIN-  and -  was excised from the pCMV-FlagEP-
LIN plasmids (Maul and Chang, 1999) and cloned into the pTRE vector
(CLONTECH Laboratories, Inc.). The pTRE/EPLIN plasmids and a puromy-
cin resistance marker were transfected into the MCF-7 cells (Tet-Off™;
CLONTECH Laboratories, Inc.), and puromycin-resistant clones were se-
lected in the presence of 2  g/ml tetracycline. Clones that expressed EPLIN
in a tightly regulated manner (expression off in the presence of doxycy-
cline) were expanded for analysis. For transient expression, HeLa cells
were plated in six-well dishes at a density of 2   10
5 cells per well and
cultured for 18 h. Two micrograms of plasmid DNA were transfected using
6  l of Dosper (Roche) according to the manufacturer’s instructions. In
co-transfection experiments, pCMV-FlagEPLIN and Rac1G12V plasmids
(Kuroda et al., 1996) were used at a ratio of 5.6:1. 40 h later, the cells were
replated on fibronectin-coated glass coverslips for 3 h before fixing them in
3.7% formaldehyde in PBS. HA-epitope–tagged Rac1G12V was detected
with monoclonal anti-HA antibody (1:300; Santa Cruz Biotechnology,
Inc.), whereas endogenous EPLIN was detected with polyclonal anti-EPLIN
sera (1:300; Maul and Chang). Actin filaments were stained with rho-
damine-conjugated phalloidin (Molecular Probes Inc.).
Measurement for actin stress fibers
The quantitative changes in actin stress fibers in MCF-7 cells after the in-
duction of EPLIN were estimated from the fluorescence intensities of
rhodamine-phalloidin staining. Images were digitally captured at a fixed
exposure time (248 ms for EPLIN- , and 308 ms for EPLIN- ) and analyzed
by using IQMac v1.2 software (Amersham Biosciences). Arbitrary units of
fluorescence intensities per cell were 2,314,281   1,268,755 (MCF-7/EP-
LIN-  ON; n   20); 1,107,451   536,852 (MCF-7/EPLIN-  OFF; n   28);
3,659,482   1,649,809 (MCF-7/EPLIN-  ON; n   13); and 988,320  
321,784 (MCF-7/EPLIN-  OFF; n   16).
Protein purification
The coding region of EPLIN-  was cloned into the pGEX-4T1 (Amersham
Biosciences) and pQE30 (QIAGEN) vectors to generate GST-EPLIN-  and
his-EPLIN- , respectively. Transformed bacterial cells (BL21) were cul-
tured in LB-amp at 37 C to an early exponential phase of growth (OD600  
0.5) before the addition of 1 mM IPTG. After an additional 3 h, bacterial
cells were harvested and lysed by sonication in a PBS buffer containing
1% Triton X-100, 500 mM NaCl, and 25 mM EDTA. The cleared lysates
were incubated with glutathione-Sepharose beads (Sigma-Aldrich). Bound
GST-fusion protein was eluted from the beads with 10 mM free glutathione
in 25 mM Tris, pH 8.0, for  1 h at RT. His-EPLIN-  was prepared by incu-
bating cleared lysates with Ni-NTA beads (QIAGEN). The Ni-NTA beads
were extensively washed in 40 mM imidazole and 300 mM NaCl in 50
mM Tris, pH 8.0, and the fusion protein was eluted with 100 mM imida-
zole in 50 mM Tris, pH 8.0. His-EPLIN-  in 100 mM imidazole, 50 mM
Tris, pH 8.0, and 0.5 mM DTT eluted from a Superose 6 gel filtration col-
umn as a single, symmetrical peak with a Stokes radius of 61Å between
catalase (RS 52.2 Å) and ferritin (RS 67 Å; de Haen, 1987). Sedimentation
equilibrium analytical ultracentrifugation of his-EPLIN-  at three initial
concentrations (A280   0.1, 0.2, and 0.4) in 100 mM imidazole, 50 mM
Tris, pH 8.0 for 24 h at 8 C gave an average mol wt of 621. Production and
purification of Scar1-WA domain (Scar-WA), Arp2/3 complex, and profi-
lin-I were described previously (Kaiser et al., 1986; Higgs et al., 1999).
Spectrin-actin seeds were prepared from human erythrocytes using the
method of Lin and Lin (Lin and Lin, 1980).  -actinin was purchased from
Cytoskeleton Inc.
Binding assays
Binding of EPLIN-  to monomeric actin was tested in a GST-pull-down as-
say. Two  g of immobilized GST fusion proteins were incubated for 1 h at
4 C with 50 nM G-actin in 100 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 1
mM DTT, 0.1% (vol/vol) Tween 20, 0.2 mM ATP, and 0.5 mg/ml BSA in
10 mM Hepes, pH 7.6. This actin concentration is below the critical con-
centration. The GST-VCA construct was provided by M. Kirschner (Har-
vard Medical School, Boston, MA. Beads were washed three times, bound
actin was eluted with SDS sample buffer, run on an SDS-PAGE, and immu-
noblotted with anti-actin antibody (Santa Cruz Biotechnology, Inc.). 
Actin filament pelleting assay
G-actin and recombinant EPLIN proteins were first precleared by centrifu-
gation at 150,000 g for 30 min at 4 C. Actin was polymerized in 50 mM
KCl, 2 mM MgCl2, 0.2 mM ATP, and 0.2 mM DTT in 2 mM Tris, pH 7.5, at
24 C for 1 h and then incubated with EPLIN for 30 min at 24 C. After cen-
trifuging at 150,000 g for 30 min at 24 C, the supernatant and pellet were
separated and analyzed by SDS-PAGE and Coomassie blue staining. The
quantity of protein in supernatant and pellet fractions was measured by
digitizing stained gels.
Actin cross-linking/bundling assay
His-EPLIN-  or  -actinin was mixed with 10  M freshly prepared F-actin
for 30 min at RT, and was then centrifuged at 8,000 g for 20 min at 24 C.
The supernatant and pellet were separated and analyzed by SDS-PAGE
and Coomassie blue staining. For electron microscopy study, 2  M F-actin
was incubated in the presence of 1  M his-EPLIN-  or 1  M BSA for 30
min at 24 C. The mixture was absorbed onto carbon-coated electron mi-
croscope grids and negatively stained with 0.2% uranyl acetate. Electron
micrographs were obtained using a transmission electron microscope
(model 10C; Carl Zeiss MicroImaging, Inc.) at a magnification of 45,000.
Actin polymerization assays
Purified G-actin (5% pyrene-labeled) in Buffer G (0.1 mM CaCl2, 0.2 mM
ATP, 0.5 mM DTT, and 2 mM Tris, pH 8.0) was converted to Mg-ATP-actin
by incubation in 0.1 mM MgCl2 and 1 mM EGTA for 2 min at 22 C. Ali-
quots of various proteins (Arp2/3 complex, Scar-WA, and EPLIN fusion pro-
teins) in Buffer G (as above, but with 2 mM imidazole, pH 7.0) were added,
and polymerization was initiated with 0.1 vol of 10  polymerization buffer
(500 mM KCl, 10 mM MgCl2, 10 mM EGTA, and 100 mM imidazole, pH
7.0). The polymer concentration was monitored over time with a Spectro-
fluorimeter (excitation at 365 nm and emission at 407 nm; Photon Technol-
ogy Instruments). To measure depolymerization, polymerized filaments
were diluted to the critical concentration with 20 vol of polymerization
buffer. For barbed-end elongation, 9 nM spectrin-actin seeds were added.
Fluorescence microscopy of branched actin filaments
Mixtures of actin, Arp2/3 complex, Scar-WA, and GST-EPLIN-  were poly-
merized in the presence of 4  M rhodamine-phalloidin (Amann and Pol-
lard, 2001). After incubation for 2 min at 24 C, aliquots were diluted
500-fold in polymerization buffer with 0.5% methylcellulose, 20  g/ml
catalase, 100  g/ml glucose oxidase, and 3 mg/ml glucose. 1.6- l sam-
ples were applied to coverslips (22   22 mm) coated with 20  g/ml poly-
L-lysine and viewed with a microscope (model IX-70; Olympus). Branches
were verified as not being merely artifacts of overlain filaments by visualiz-
ing their Brownian vibration. Random fields were selected and the number
of branched filaments was enumerated.
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